Efficacious Transition From Reference Infliximab to Biosimilar Infliximab in Clinical Practice

International Journal of Rheumatic Diseases - United Kingdom
doi 10.1111/1756-185x.13512
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Wiley

Related search

PF-06438179/GP1111: An Infliximab Biosimilar

BioDrugs
MedicineBiotechnologyPharmacology
2018English

THU0218 the Efficacy and Drug Survival of the Biosimilar Infliximab (CT-P13) Compared to the Original Reference Infliximab in Inflammatory Rheumatic Diseases; Results From the Turkbio Registry

2018English

Switching Maintenance Infliximab Therapy to Biosimilar-Infliximab Does Not Lead to Significant Changes in Health-Related Quality of Life and Clinical Outcomes in Inflammatory Bowel Disease Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Comparative Clinical Efficacy and Safety of the Proposed Biosimilar ABP 710 With Infliximab Reference Product in Patients With Rheumatoid Arthritis

Arthritis Research & Therapy
2020English

Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar

BioDrugs
MedicineBiotechnologyPharmacology
2019English

Letter: Is There a Role for Infliximab Biosimilar in Patients With Inflammatory Bowel Disease With Secondary Loss of Response to Infliximab Innovator?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Pregnancy Outcomes in Women With Inflammatory Bowel Disease Treated With Biosimilar Infliximab

Gastroenterologie a Hepatologie
HepatologyGastroenterology
2018English

AB0389 the Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses

2017English

Patient Perspectives on Switching From Infliximab to Infliximab‐dyyb in Patients With Rheumatologic Diseases in the United States

ACR Open Rheumatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy